Table 3. Study characteristics of studies meeting inclusion criteria but excluded from final analysis because the study population (i.e. community-based, inpatient, or outpatient) was not given or results were not stratified by group.
Author (ref) | Country | Date of data collection | Study duration (months) | Age in yrs (mean ± range) | Sample size | Pathogens included in study |
Echevarria [55] | Thailand | 1982–83 | 12 | ≥5 | 177 | ETEC, Shigella spp., Aeromonas spp., V. cholerae, V. parahaemolyticus |
Chatterjee [41] | India | 1982–83 | 24 | 5–14 | 46 | EIEC, EPEC, Salmonella spp., Shigella spp., Campylobacter spp., Rotavirus, Giardia, E. histolytica, V. cholerae, V. parahaemolyticus, P. shigelloides |
Cabrita [39] | Portugal | 1984–89 | 72 | ≥5 | 1012 | Salmonella spp., Shigella spp., Campylobacter spp. |
Rahman [48] | Bangladesh | 1985 | 12 | ≥6 | 577 | Cryptosporidium spp. |
Bingnan [38] | Bangladesh | 1987–89 | 24 | ≥5 | 2370 | Rotavirus |
Zvizdic [53] | Bosnia | 1988–1991 | 48 | 5–7 | 70 | Rotavirus |
Cassel-Beraud [40] | Madagascar | 1988–89 | 12 | 6–14 | 113 | ETEC, Salmonella spp., Shigella spp., Campylobacter spp., Rotavirus, Giardia, E. histolytica |
Zaman [20] | Saudi Arabia | 1989–90 | 12 | ≥5 | 901 | Campylobacter spp. |
Libanorne [47] | Italy | 1984–87 | 24 | 16–96 | 1681 | Giardia |
Katsumata [46] | Indonesia | 1992–93 | 12 | ≥5 | 211 | Cryptosporidium spp. |
Samonis [49] | Greece | 1992–94 | 36 | ≥15 | 1420 | EPEC, Salmonella spp., Shigella spp., Campylobacter spp., Aeromonas spp. |
Simadibrata [50] | Indonesia | 1995–2000 | 72 | (42±14) | 207 | Shigella spp.,Giardia, E. histolytica |
Akinyemi [34] | Nigeria | 1995–96 | 12 | ≥6 | 642 | EHEC, EIEC, ETEC, EPEC, Salmonella spp., Shigella spp., Aeromonas spp. |
Faruque [42] | Bangladesh | 1996–2001 | 72 | ≥5 | 5779 | ETEC, EPEC, Salmonella spp., Shigella spp., Campylobacter spp., Rotavirus, E histolytica, V. cholerae |
Bern [37] | Guatemala | 1997–98 | 12 | ≥5 | 514 | Cryptosporidium spp. |
Gambhir [44] | India | 1997–2000 | 36 | ≥15 | 145 | Giardia, Cryptosporidium spp., E. histolytica |
Battikhi [36] | Jordan | 1997–2001 | 48 | ≥5 | 560 | EPEC, Salmonella spp., Shigella spp., Campylobacter spp., Rotavirus |
von Seidlein [52] | Multi-site Asia1 | 2002 | 12 | >5 | 8253 | Shigella spp. |
Abreu-Acosta [33] | Spain | 2002–2004 | 24 | ≥13 | 17 | Cryptosporidium spp. |
Hamedi [45] | Iran | 2003 | 12 | 5–7 | 31 | Cryptosporidium spp. |
Uchida [51] | Nepal | 2003–04 | 12 | ≥5 | 645 | Rotavirus |
Amarilla [35] | Paraguay | 2004–05 | 24 | 18–95 | 801 | Rotavirus |
Feizabadi [43] | Iran | 2004–05 | 12 | 5–14 | 79 | Campylobacter spp. |
China, Thailand, Indonesia, Vietnam, Pakistan, Bangladesh.